Published in Healthcare Mergers, Acquisitions and Ventures Week, February 26th, 2005
Fourth quarter revenue is expected to increase more than 28% to approximately $7.2 million, compared with revenue of $5.6 million reported for the fourth quarter ended December 31, 2003.
For the 12-month period ended December 31, 2004, revenue is expected to grow approximately 52% to $28.0 million compared with $18.5 million for the 12-month period ended December 31, 2003. These results are in line with the guidance the company provided when it reported its 2004 third quarter results on October 27, 2004.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.